| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 2,155,100 | 239,927,000 | 21.31% | ||
| 2 | INOGEN INC COM | 3,549,320 | 212,604,000 | 18.88% | ||
| 3 | OPHTHOTECH CORP COM | 3,610,487 | 166,552,000 | 14.79% | ||
| 4 | COLUCID PHARMACEUTICALS INC COM | 3,156,563 | 120,423,000 | 10.69% | ||
| 5 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 102,382,000 | 9.09% | ||
| 6 | REATA PHARMACEUTICALS INC | 3,367,763 | 88,774,000 | 7.88% | ||
| 7 | CORVUS PHARMACEUTICALS INC COM | 3,224,046 | 53,036,000 | 4.71% | ||
| 8 | ACCELERON PHARMA | 903,833 | 32,710,000 | 2.91% | ||
| 9 | SPECTRANETICS CORP | 1,155,722 | 28,997,000 | 2.58% | ||
| 10 | MERUS N V | 1,410,417 | 23,624,000 | 2.10% | ||
| 11 | FLEXION THERAPEUTICS INC COM | 1,097,718 | 21,449,000 | 1.90% | ||
| 12 | INVUITY INC | 1,285,448 | 17,636,000 | 1.57% | ||
| 13 | Nabriva Therapeutics AG | 1,116,660 | 7,872,000 | 0.70% | ||
| 14 | WRIGHT MED GROUP N V | 4,622,032 | 6,055,000 | 0.54% | PRN | |
| 15 | HTG MOLECULAR DIAGNOSTICS IN | 1,280,185 | 2,906,000 | 0.26% | ||
| 16 | XENON PHARMACEUTICALS INC | 127,563 | 1,033,000 | 0.09% | ||
| 17 | OPKO HEALTH INC | 259 | 3,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-022226, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
